Zemplar and sepsis Patient Reports February 10, 2012

Zemplar Side Effects Report #5938025-7
Zemplar side effect was reported by a Physician from DENMARK on Oct 24, 2008. Male patient, weighting 231.5 lb, was diagnosed with secondary hyperthyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, diarrhoea, sepsis , skin ulcer. Zemplar dosage: unknown. During the same period patient was treated with RENAGEL. Patient died on 02/01/2008.

Zemplar Side Effects Report #5943884-8
Zemplar side effect was reported by a Physician from DENMARK on Nov 03, 2008. Male patient, weighting 231.5 lb, was diagnosed with secondary hyperthyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, diarrhoea, sepsis , skin ulcer. Zemplar dosage: unknown. Patient died on 02/01/2008.

Zemplar Side Effects Report #5946865-3
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2008. Male patient, weighting 200.2 lb, was diagnosed with renal failure chronic, restless legs syndrome, gastric disorder, cardiac disorder, blood pressure  and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cholecystitis, cholelithiasis, depression , hallucination, personality change, sepsis , sleep talking, unevaluable event. Zemplar dosage: unknown. During the same period patient was treated with MERAPEX, PROLOZOL, AMIODARONE, DILTIAZEM, BUMETANIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5656908-2
Zemplar side effect was reported by a Physician from GERMANY on Feb 29, 2008. Female patient, weighting 176.4 lb, was diagnosed with renal failure and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fat necrosis, lipomatosis, sepsis . Zemplar dosage: unknown. During the same period patient was treated with GLIMEPIRIDE, XIPAMIDE, NEBIVOLOL, MOXONIDINE, DOXAZOSIN MESYLATE, FLUVASTATIN, ESOMEPRAZOLE MAGNESIUM, CALCIUM ACETATE. Patient died.


Zemplar Side Effects Report #5804864-6
Zemplar side effect was reported by a Physician from GERMANY on July 05, 2008. Female patient, weighting 176.4 lb, was diagnosed with renal failure and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fat necrosis, lipomatosis, sepsis . Zemplar dosage: unknown. During the same period patient was treated with GLIMEPIRIDE, XIPAMIDE, NEBIVOLOL, MOXONIDINE, DOXAZOSIN MESYLATE, FLUVASTATIN, ESOMEPRAZOLE MAGNESIUM, CALCIUM ACETATE. Patient died.

Zemplar Side Effects Report #5092765-3
Zemplar side effect was reported by a Physician from GERMANY on Apr 27, 2006. Female patient, 80 years of age, weighting 152.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: sepsis . Zemplar dosage: unknown. During the same period patient was treated with DIGITOXIN, ISOSORBIDE MONONITRATE, CALCIUM CARBONATE, ANTIPHOSPHATE. Patient died on 11/03/2005.

Zemplar Side Effects Report #4994719-1
Zemplar side effect was reported by a Physician from GERMANY on Apr 27, 2006. Female patient, 80 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: sepsis . Zemplar dosage: unknown. During the same period patient was treated with DIGITOXIN, ISOSORBIDE MONONITRATE, CALCIUM CARBONATE, ANTIPHOSPHATE. Patient died on 11/03/2005.

Zemplar Side Effects Report #5176594-8
Zemplar side effect was reported by a Physician from GERMANY on Dec 06, 2006. Female patient, 72 years of age, weighting 227.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , cellulitis , sepsis , thrombophlebitis. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, ASPIRIN, PRAVASIN PROTECT, ISOSORBIDE DINITRATE, ZOLPIDEM TARTRATE, CITALOPRAM HYDROBROMIDE, GABAPENTIN, PHOSEX. Patient died on 09/01/2006.

Zemplar Side Effects Report #5289839-0
Zemplar side effect was reported by a Physician from AUSTRIA on Mar 29, 2007. Female patient, 71 years of age, weighting 105.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, intestinal perforation, peritoneal infection, sepsis . Zemplar dosage: unknown. During the same period patient was treated with ANTIPHOSPHAT, SEVELAMER HYDROCHLORIDE. Patient died on 08/24/2006.


Zemplar Side Effects Report #5291301-6
Zemplar side effect was reported by a Physician from AUSTRIA on Mar 30, 2007. Female patient, 71 years of age, weighting 105.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: gastrointestinal necrosis, intestinal perforation, peritoneal infection, sepsis . Zemplar dosage: unknown. During the same period patient was treated with ANTIPHOSPHAT, SEVELAMER HYDROCHLORIDE. Patient died on 08/24/2006.

Zemplar Side Effects Report #5320941-0
Zemplar side effect was reported by a Physician from AUSTRIA on May 02, 2007. Female patient, 66 years of age, weighting 246.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: sepsis , vascular bypass graft. Zemplar dosage: unknown. During the same period patient was treated with ANTIPHOS, ALFACALCIDOL. Patient died on 04/09/2006.

Zemplar Side Effects Report #4986876-8
Zemplar side effect was reported by a Physician from AUSTRIA on Apr 18, 2006. Female patient, 66 years of age, weighting 246.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: sepsis , vascular bypass graft. Zemplar dosage: unknown. During the same period patient was treated with ANTIPHOS, ALFACALCIDOL. Patient died on 04/09/2006.

Zemplar Side Effects Report #4784842-9
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Sept 20, 2005. Female patient, 65 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cholangitis, cholelithiasis, haemolysis, pancreatitis, sepsis . Zemplar dosage: unknown. During the same period patient was treated with ERGOCALCIFEROL. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5471250-0
Zemplar side effect was reported by a Physician from GREECE on Sept 24, 2007. Female patient, 62 years of age, weighting 137.8 lb, was diagnosed with hyperparathyroidism secondary, anaemia, carnitine decreased, vitamin supplementation, peripheral vascular disorder, coronary artery disease , hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: femoral artery occlusion, gangrene, pneumonia , sepsis . Zemplar dosage: unknown. During the same period patient was treated with EPOETIN BETA, INTELLECTA, CERNEVIT, BUFLOMEDIL HYDROCHLORIDE, ASPIRIN, FORSENOL. Patient was hospitalized. Patient died on 09/23/2007.


Zemplar Side Effects Report #5684987-5
Zemplar side effect was reported by a Physician from GREECE on Mar 26, 2008. Female patient, 62 years of age, weighting 137.8 lb, was diagnosed with hyperparathyroidism secondary, anaemia, carnitine decreased, vitamin supplementation, peripheral vascular disorder, coronary artery disease , hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: femoral artery occlusion, gangrene, pneumonia , sepsis . Zemplar dosage: unknown. During the same period patient was treated with EPOETIN BETA, INTELLECTA, CERNEVIT, BUFLOMEDIL HYDROCHLORIDE, ACETYLSALICYLIC ACID SRT, FORSENOL. Patient was hospitalized. Patient died on 09/23/2007.

Zemplar Side Effects Report #5100171-8
Zemplar side effect was reported by a Physician from GERMANY on Aug 28, 2006. Male patient, 46 years of age, weighting 271.2 lb, was diagnosed with hyperparathyroidism secondary, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, diabetic gangrene, hepatic failure, sepsis . Zemplar dosage: unknown. During the same period patient was treated with PHOSPHOSORB, CALCITRIOL, COLECALCIFEROL, NPH INSULIN, DIGITOXIN, FOLIC ACID, LIPIDIL, METOPROLOL SUCCINATE. Patient was hospitalized. Patient died on 11/07/2005.

Zemplar Side Effects Report #5200140-3
Zemplar side effect was reported by a Physician from GERMANY on Dec 28, 2006. Female patient, weighting 227.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , cellulitis , sepsis , shock, thrombophlebitis. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, ASPIRIN, PRAVASIN PROTECT, ISOSORBIDE DINITRATE, ZOLPIDEM TARTRATE, CITALOPRAM HYDROBROMIDE, GABAPENTIN, PHOSEX. Patient died on 09/01/2006.

Zemplar Side Effects Report #5122206-9
Zemplar side effect was reported by a Physician from GERMANY on Sept 27, 2006. Female patient, weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: sepsis . Zemplar dosage: unknown. During the same period patient was treated with CALCIUM. Patient was hospitalized. Patient died on 07/14/2006.

Zemplar Side Effects Report #5176667-X
Zemplar side effect was reported by a Physician from GERMANY on Sept 14, 2006. Female patient, weighting 145.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fall , postoperative wound infection, sepsis , tibia fracture. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 06/26/2006.


Zemplar Side Effects Report #5176668-1
Zemplar side effect was reported by a Physician from GERMANY on Sept 14, 2006. Female patient, weighting 145.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fall , postoperative wound infection, sepsis , tibia fracture. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 06/26/2006.

Zemplar Side Effects Report #5440550-2
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Aug 22, 2007. Male patient, weighting 185.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: pseudomonas infection, sepsis . Zemplar dosage: unknown. Patient was hospitalized. Patient died on 06/23/2007.

Zemplar Side Effects Report #5700344-7
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Mar 31, 2008. Male patient, weighting 143.3 lb, was diagnosed with hyperparathyroidism secondary, iron deficiency and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, coronary artery disease , diabetic gangrene, hypertension, myocardial infarction, peripheral arterial occlusive disease, sepsis , type 2 diabetes mellitus. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, PENTAERITHRITYL TETRANITRATE, RAMIPRIL, SIMVASTATIN, THIAMAZOLE, EPOETIN BETA, FERRLECIT. Patient died on 07/23/2007.

Zemplar Side Effects Report #5740999-4
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on May 09, 2008. Female patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, catheter related complication, dialysis device complication, fluid retention, hyperkalaemia, sepsis . Zemplar dosage: unknown. During the same period patient was treated with ALFACALCIDOL, AMIODARONE, ESOMEPRAZOLE, ACETYLSALICYLIC ACID SRT, BISOPROLOL FUMARATE, AMITRIPTYLINE, PREGABALIN, CELECOXIB. Patient died on 02/01/2007.

Zemplar Side Effects Report #4745773-3
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Aug 08, 2005. Male patient, weighting 127.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: amputation revision, gangrene, leg amputation, sepsis . Zemplar dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.


Zemplar Side Effects Report #4815094-9
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Aug 08, 2005. Male patient, weighting 127.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: amputation revision, gangrene, leg amputation, sepsis . Zemplar dosage: unknown. During the same period patient was treated with OSTEOTRIOL, MIMPARA, FERRIC GLUCONATE, CYANOCOBALAMIN, BETAXOLOL, IRBESARTAN, AMLODIPINE BESYLATE. Patient was hospitalized and became disabled. Patient recovered.

Zemplar Side Effects Report #4960181-8
Zemplar side effect was reported by a Physician from GERMANY on Mar 23, 2006. Male patient, weighting 233.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: large intestine perforation, sepsis . Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, FUROSEMIDE, ALLOPURINOL, ALUMINIUM HYDROXIDE GEL, RESTEX RETARD. Patient was hospitalized. Patient died on 02/02/2006.

Zemplar Side Effects Report #4967070-3
Zemplar side effect was reported by a Physician from GERMANY on Mar 23, 2006. Male patient, weighting 233.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: large intestine perforation, procedural complication, sepsis . Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, FUROSEMIDE, ALLOPURINOL, ALUMINIUM HYDROXIDE GEL, RESTEX RETARD. Patient was hospitalized. Patient died on 02/03/2006.

Zemplar Side Effects Report #6098701-5
Zemplar side effect was reported by a Physician from GERMANY on Feb 25, 2009. Male patient, 85 years of age, weighting 174.2 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abscess , sepsis . Zemplar dosage: unknown. Patient was hospitalized. Patient died on 01/05/2009.

Zemplar Side Effects Report #5234678-X
Zemplar side effect was reported by a Physician from AUSTRIA on Jan 30, 2007. Female patient, 83 years of age, weighting 158.7 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal operation, azotaemia, blood parathyroid hormone increased, haematemesis, ileus, sepsis , umbilical hernia. Zemplar dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, FUROSEMIDE, PROTHIPENDYL HYDROCHLORIDE, MADOPAR, SORMORDREN, FORADIL DA, NULYTELY. Patient was hospitalized. Patient died on 10/17/2006.


Zemplar Side Effects Report #5168361-6
Zemplar side effect was reported by a Physician from AUSTRIA on Nov 29, 2006. Female patient, 83 years of age, weighting 158.7 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal operation, azotaemia, blood parathyroid hormone increased, sepsis . Zemplar dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, FUROSEMIDE, PROTHIPENDYL HYDROCHLORIDE, MADOPAR, SORMORDREN, FORADIL DA, NULYTELY. Patient was hospitalized. Patient died on 10/17/2006.

Zemplar Side Effects Report #6055294-6
Zemplar side effect was reported by a Consumer or non-health professional from on Jan 20, 2009. Male patient, 62 years of age, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: ascites, candidiasis, fungal infection , pain in extremity, purulent discharge, sepsis , serratia infection, skin exfoliation, skin ulcer. Zemplar dosage: 5 MCG/ML. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #6075351-8
Zemplar side effect was reported by a Consumer or non-health professional from on Feb 06, 2009. Male patient, 62 years of age, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: ascites, candidiasis, fungal infection , pain in extremity, purulent discharge, sepsis , serratia infection, skin exfoliation, skin ulcer. Zemplar dosage: 5 MCG/ML. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5930177-8
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Oct 14, 2008. Male patient, 60 years of age, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, diarrhoea, episcleritis, oxygen saturation decreased, sepsis , vena cava thrombosis. Zemplar dosage: 5 MCG/ML, 1 ML ONCE A WEEK. During the same period patient was treated with OMEPRAZOLE, TRIOBE, PARENTROVITE, PYRIDOXINE HYDROCHLORIDE, CALCIUM CARBONATE, WARFARIN, METOPROLOL TARTRATE, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5612765-1
Zemplar side effect was reported by a Consumer or non-health professional from AUSTRIA on Jan 25, 2008. Male patient, weighting 175.3 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arteriosclerosis, arteriosclerosis coronary artery, colitis erosive, pancreatitis necrotising, pericarditis, sepsis . Zemplar dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, LOSARTAN POTASSIUM, PANTOPRAZOLE, DILZEM RETARD, PHENPROCOUMON, AMIODARONE. Patient died on 06/22/2007.


Zemplar Side Effects Report #4749345-6
Zemplar side effect was reported by a Consumer or non-health professional from BELGIUM on June 17, 2005. Male patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism, blood phosphorus increased, gastric disorder, chronic obstructive pulmonary disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal discomfort, anorexia, colitis ischaemic, dyspnoea, infrequent bowel movements, malaise, sepsis , urinary tract infection , urine output decreased. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, NADROPARIN, NITROGLYCERIN, NATRIUMBICARBONAT, DOMPERIDON, DUOVENT. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #4754853-8
Zemplar side effect was reported by a Consumer or non-health professional from BELGIUM on June 17, 2005. Male patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism, blood phosphorus increased, gastric disorder, chronic obstructive pulmonary disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abdominal discomfort, anorexia, colitis ischaemic, dyspnoea, gastroenteritis , infrequent bowel movements, malaise, sepsis , urinary tract infection . Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, NADROPARIN, NITROGLYCERIN, NATRIUMBICARBONAT, DOMPERIDON, DUOVENT. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #4843154-5
Zemplar side effect was reported by a Consumer or non-health professional from AUSTRIA on Nov 23, 2005. Female patient, weighting 144.4 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: diabetic gangrene, sepsis . Zemplar dosage: unknown. During the same period patient was treated with ANTIPHOSL, DREISACARB, CALCITRIOL. Patient died on 11/01/2005.